Skip to main content
Clinical Trials/NCT07376070
NCT07376070
Active, not recruiting
Not Applicable

The Role of Inflammatory Biomarkers in Preventing Deep Sternal Wound Infections After Sternotomy

Levan Nebieridze2 sites in 1 country30 target enrollmentStarted: April 14, 2025Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Levan Nebieridze
Enrollment
30
Locations
2
Primary Endpoint
change in pre and postoperative inflammatory biomarker levels associated with development of deep sternal wound infection within 1 month

Overview

Brief Summary

The goal of this observational study is to reveal blood biomarkers that will have prognostic significance in terms of the development of deep wound infection following sternotomy. As for the practical significance of the study, blood biomarkers correlated with deep wound infections can be used to prevent the development of wound infections in the postoperative period. Based on this, it is possible to formulate an algorithm for preventive measures.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • deep sternal wound infection

Exclusion Criteria

  • bilateral internal thoracic artery graft

Outcomes

Primary Outcomes

change in pre and postoperative inflammatory biomarker levels associated with development of deep sternal wound infection within 1 month

Time Frame: within 30 days after surgery

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Levan Nebieridze
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Levan Nebieridze

Junior physician, cardiac surgery

Tbilisi State Medical University

Study Sites (2)

Loading locations...

Similar Trials